| Code | 21157 | ||||||||||
| MA number | 44/0239/89-CS | ||||||||||
| Product Form: | tbl flm 100x2 mg (liek.skl.jant.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Aspen Pharma Trading Limited, Ireland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | amber glass container | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 24.11.1989 |
| Pediatric indication: | Yes |
| SPC: |
SPC_Myleran 2 mg_05.2025.pdf
|
| PIL: |
PIL_Myleran 2 mg_05.2025.pdf
|
| Safety feature | Yes |
| Data update: | 20.02.2018 |
